On Sept. 17, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 16, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 15, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 12, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 11, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
CBP said the FDA will hold an extended downtime from Sept. 13 10 p.m. through 6 a.m. Sept. 14 ET as the agency installs a critical security update, according to a Sept. 12 cargo systems message.
On Sept. 10, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 8, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 5, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:
The FDA is developing a list, called a "green list," aimed at preventing the importation of glucagon-like peptide-1 (GLP-1) active pharmaceutical ingredients (APIs) from unverified foreign sources, according to an agency release.